Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 6, 2004, Pages 1100-1104

  Southern, Jo ^a   Deane, Sarah ^a   Ashton, Lindsey ^b   Borrow, Ray ^a   Goldblatt, David ^b   Andrews, Nick ^a   Balmer, Paul ^a   Morris, Rhonwen ^a   Kroll, J Simon ^c   Miller, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; TETANUS TOXOID;

ADULT; ARTICLE; BLOOD GROUP TYPING; CLINICAL ARTICLE; CONTROLLED STUDY; EDEMA; FATIGUE; FEMALE; HEADACHE; HUMAN; IMMUNE RESPONSE; INJECTION PAIN; MALAISE; MALE; NAUSEA; PRIORITY JOURNAL; RISK ASSESSMENT; SEROLOGY; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VOMITING;

ADULT; ANTIBODIES, BACTERIAL; CONSUMER PRODUCT SAFETY; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; MALE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP C; POLYSACCHARIDES, BACTERIAL; SERUM BACTERICIDAL TEST; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 9144241845     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.6.1100-1104.2004     Document Type: Article

References (25)

1. Abarca, K., F. Valdivieso, M. Potin, I. Ibanez, and P. Vial. 2002. Immunogenicity and reactogenicity of a reduced antigen content diphtheria, tetanus and acellular pertussis vaccine (dTPa) in 10 to 11 year old children and in adults. Rev. Med. Chil. 130:502-510.
2. Amato, N. V., H. Finger, E. C. Gotschlich, R. A Feldman, C.A. de Avila, and S. R. Konichi. 1974. Serological response to serogroup C meningococcal vaccine in Brazilian preschool: children. Rev. Inst. Med. Trop. Sao Paulo 16:149-153.
3. Andrews, N., R. Borrow, and E. Miller. 2003. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin. Diagn. Lab. Immunol. 10:780-786.
4. Borrow, R., J. Southern, N. Andrews, N. Peake, R. Rahim, M. Acuna, S. Martin, E. Miller, and E. Kaczmarski. 2001. Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controls. Vaccine 19:3043-3050.
5. Borrow, R., D. Goldblatt, N. Andrews, P. Richmond, J. Southern, and E. Miller. 2001. Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children. J. Infect. Dis. 184:377-380.
6. Borrow, R., N. Andrews, D. Goldblatt, and E. Miller. 2001. Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect. Immun. 69:1568-1573.
7. Bruguera, M., J. M. Bayas, A. Vilella, C. Tural, A. Gonzalez, J. Vidal, R. Dal-Re, and L. Salleras. 1996. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults. Vaccine 14:1407-1411.
8. Fairley, C. K., N. Begg, R. Borrow, A. J. Fox, D. M. Jones, and K. A. V. Cartwright. 1996. Reactogenicity and immunogenicity of conjugate meningococcal serogroup A and C vaccine in UK infants. J. Infect. Dis. 174:1360-1363.
9. Gheesling, L. L., G. M. Carlone, L. B. Pais, P. F. Holder, S. E. Maslanka, B. D. Plikaytis, M. Achtman, P. Densen, C. E. Frasch, and H. Käyhty. 1994. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J. Clin. Microbiol. 32:1475-1482.
10. Goldblatt, D. 1997. Simple solid phase assays of avidity, p. 31-51. In M. W. Turner and A. P. Johnson (ed.), Immunochemistry 2: a practical approach. IRL Press at Oxford University Press, Oxford, United Kingdom.
11. Goldblatt, D., R. Borrow, and E. Miller. 2002. Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults. J. Infect. Dis. 185:397-400.
12. Granoff, D. M., R. K. Gupta, R. B. Belshe, and E. L. Anderson. 1998. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. J. Infect. Dis. 178:870-874.
13. Griffis, J. M., and D. K. Goroff. 1983. IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms. J. Immunol. 130:2882-2885.
14. Jarvis, G. A., and J. M. Griffiss. 1991. Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule. J. Immunol. 147:1962-1967.
15. Maslanka, S. E., L. L. Gheesling, D. E. Libutti, K. B. Donaldson, H. S. Harakeh, J. K. Dykes, F. F. Arhin, S. J. Devi, C. E. Frasch, J. C. Huang, P. Kriz-Kuzemenska, R. D. Lemmon, M. Lorange, C. C. Peeters, S. Quataert, J. Y. Tai, and G. M. Carlone. 1997. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Clin. Diagn. Lab. Immunol. 4:156-167.
16. Miller, E., D. Salisbury, and M. Ramsay. 2001. Planning, registration, and implementation of an immunisation campaign against meningococcal sero-group C disease in the UK: a success story. Vaccine 20:S58-S67.
17. Mitchell, L. A., J. J. Ochnio, C. Glover, A. Y. Lee, M. K. Ho, and A. Bell. 1996. Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents. J. Infect. Dis. 173:1009-1013.
18. Richmond, P., R. Borrow, E. Miller, S. Clark, F. Sadler, A. Fox, N. Begg, R. Morris, and K. Cartwright. 1999. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J. Infect. Dis. 179:1569-1572.
19. Richmond, P., D. Goldblatt, P. C. Fusco, J. D. S. Fusco, I. Heron, S. Clark, R. Borrow, and F. Michon. 1999. Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine 18:641-646.
20. Richmond, P., E. Kaczmarski, R. Borrow, J. Findlow, S. Clark, R. McCann, J. Hill, M. Barker, and E. Miller. 2000. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J. Infect. Dis. 181:761-764.
21. Richmond, P., R. Borrow, J. Findlow, S. Martin, C. Thornton, K. Cartwright, and E. Miller. 2001. Evaluation of de-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and de-O-acetylated serogroup C strains. Infect. Immun. 69:2378-2382.
22. Richmond, P., R. Borrow, D. Goldblatt, J. Findlow, S. Martin, R. Morris, K. Cartwright, and E. Miller. 2001. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J. Infect. Dis. 183:160-163.
23. Rosenqvist, E., and E. A. Hoiby. 1990. Relative bactericidal activity of IgG antibodies against outer membrane complex from meningococci, as a function of vaccine type, dose and time after vaccination, p. 265-269. In M. Achtman, P. Kohl, C. Marchal, G. Morelli, A. Seiler, and B. Thiesen (ed.), Neisseriae-1990. Walter de Gruyter, Berlin, Germany.
24. Taunay, A. E., R. A. Feldman, C. O. Bastos, P. A. A. Galvao, J. S. Morais, and I. O. Castro. 1978. Evaluation of the protective effect of meningococcal serogroup C vaccine in infants aged 6-36 months Rev. Inst. Adolfo Lutz 38:77-82.
25. Van Damme, P., S. Thoelen, M. Cramm, K. De Groote, A. Safary, and A. Meheus. 1994. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. J. Med. Virol. 44:446-451.